Table 1.
Item | Pathology | X2 | P | |||
---|---|---|---|---|---|---|
Normal (n=53) | CIN 1 (n=54) | CIN 2–3 (n=87) | CC (n=54) | |||
Age | 47.258 | <0.001 | ||||
<30 (N=31) | 14 (26.42%) | 18 (33.33%) | 10 (11.49%) | 1 (1.85%) | ||
30–50 (N=130) | 28 (52.83%) | 33 (61.11%) | 58 (66.67%) | 25 (46.30%) | ||
≥50(N=61) | 11 (20.76%) | 3 (5.56%) | 19 (21.84%) | 28 (51.85%) | ||
Cervical cytology | 117.005 | <0.001 | ||||
NILM (N=75) | 41 (77.34%) | 18 (33.33%) | 11 (12.64%) | 5 (9.26%) | ||
ASCUS (N=33) | 5 (9.43%) | 13 (24.07%) | 12 (13.79%) | 3 (5.56%) | ||
>ASCUS (N=107) | 3 (77.34%) | 20 (37.04%) | 57 (65.52%) | 27 (50.00%) | ||
E2/E6 | 1.53+0.92 | 1.01+0.89 | 0.52+0.49 | 0.38+034 | 54.263 | <0.001 |
POU5F1B | 0.36+0.32 | 0.71+0.69 | 2.19+1.69 | 2.87+1.89 | 37.239 | <0.001 |
Note: P<0.05.
Abbreviations: CIN, cervical intraepithelial neoplasia; NILM, negative for intraepithelial lesion or malignancy; ASC-US, atypical squamous cells of undetermined significance; LEEP, loop electrosurgical excision; CC, cervical cancer.